Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001415889-24-002378

Options or other derivatives

  • CEO AND CHIEF MEDICAL OFFICER acquired 1,500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Thye Dirk CEO AND CHIEF MEDICAL OFFICER 2024-02-01 Grant or award · Employee Stock Option (right to buy) +1,500,000 1,500,000 D
Loading xslF345X05/form4-02022024_100215.xml…